Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey

Ozturk S., Turgutalp K., Arici M., Odabas A. R. , Altiparmak M. R. , Aydin Z., ...More

NEPHROLOGY DIALYSIS TRANSPLANTATION, vol.35, no.12, pp.2083-2095, 2020 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 12
  • Publication Date: 2020
  • Doi Number: 10.1093/ndt/gfaa271
  • Journal Indexes: Science Citation Index Expanded, Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.2083-2095
  • Keywords: COVID-19, haemodialysis, kidney disease, mortality, renal transplantation, REPLACEMENT, POPULATION, RISK


Background. Chronic kidney disease (CKD) and immunosuppression, such as in renal transplantation (RT), stand as one of the established potential risk factors for severe coronavirus disease 2019 (COVID-19). Case morbidity and mortality rates for any type of infection have always been much higher in CKD, haemodialysis (HD) and RT patients than in the general population. A large study comparing COVID-19 outcome in moderate to advanced CKD (Stages 3-5), HD and RT patients with a control group of patients is still lacking.